Mochida Pharmaceutical Co (FRA:MFY) Inventories, Finished Goods: €109.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MFY Mochida Pharmaceutical Co Ltd FRA:MFY
63 GF Score
Price €16.40
GF Value €19.45
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co Inventories, Finished Goods?

Mochida Pharmaceutical Co FRA:MFY +0.61% 63 Inventories, Finished Goods is €109.7 Mil as of Mar. 2026. GuruFocus rates FRA:MFY with a GF Score™ of 63/100 and a GF Value™ of €19.45. The stock has 4 warning signs investors should review.

Mochida Pharmaceutical Co's quarterly finished goods declined from Sep. 2025 (€118.8 Mil) to Dec. 2025 (€112.3 Mil) and declined from Dec. 2025 (€112.3 Mil) to Mar. 2026 (€109.7 Mil).

Mochida Pharmaceutical Co's annual finished goods increased from Mar. 2024 (€113.8 Mil) to Mar. 2025 (€128.4 Mil) but then declined from Mar. 2025 (€128.4 Mil) to Mar. 2026 (€109.7 Mil).

Mochida Pharmaceutical Co Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Mochida Pharmaceutical Co's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co Inventories, Finished Goods Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.70 102.33 113.82 128.37 109.71

Mochida Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.37 127.82 118.77 112.33 109.71
FRA:MFY
63GF Score
Mochida Pharmaceutical Co Ltd FRA:MFY
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mochida Pharmaceutical Co Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €109.7 Mil mean?
Mochida Pharmaceutical Co (FRA:MFY) has a Inventories, Finished Goods of €109.7 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Mochida Pharmaceutical Co and its competitors.
Is Mochida Pharmaceutical Co's Inventories, Finished Goods too high?
Mochida Pharmaceutical Co's current Inventories, Finished Goods is €109.7 Mil. Overall, Mochida Pharmaceutical Co has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's Inventories, Finished Goods compare to ZTS and UTHR?
Mochida Pharmaceutical Co's Inventories, Finished Goods of €109.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Mochida Pharmaceutical Co and its competitors. Mochida Pharmaceutical Co's current Inventories, Finished Goods is €109.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Mochida Pharmaceutical Co (FRA:MFY) has a current Inventories, Finished Goods of €109.7 Mil. The stock's GF Value™ is €19.45, compared to a current price of €16.40 — trading 15.7% below its estimated fair value. The current Inventories, Finished Goods is €109.7 Mil. Mochida Pharmaceutical Co's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Mochida Pharmaceutical Co (FRA:MFY), the current Inventories, Finished Goods is €109.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mochida Pharmaceutical Co (FRA:MFY) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of €16.40 is trading 15.7% below its estimated GF Value™ of €19.45.

Key valuation signals for FRA:MFY:

  • Inventories, Finished Goods: €109.7 Mil
  • GF Value™: €19.45 vs. price of €16.40 (15.7% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the FRA:MFY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mochida Pharmaceutical Co Business Description

Other Exchanges 4534:Japan
Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
63GF Score

Get the complete analysis for FRA:MFY

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.40
Price
€19.45
GF Value